<sup>18</sup>F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
TLR of FCH uptake is a valuable non-invasive biomarker for predicting PFS in unresectable HCC patients treated with immunotherapy.
Authors
- Jung Yong Hong (ORCID: https://orcid.org/0000-0003-1363-9332)
- Kyung-Han Lee (ORCID: https://orcid.org/0000-0003-3565-5536)
- Wonseok Whi
- SEUNG HWAN MOON
- Hyon Lee (ORCID: https://orcid.org/0000-0002-0273-8960)
- Won Jun Kang (ORCID: https://orcid.org/0000-0002-2107-8160)
- Young Seok Cho (ORCID: https://orcid.org/0000-0003-1396-4952)
- JOON YOUNG CHOI
- Seung Hyup Hyun
Institutions
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21873/anticanres.17514
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00